IP Library Granted Patent US 7,223,775
Granted Patent B2
US 7,223,775 · App. 10/510,756 · Granted May 29, 2007

Stabilized ascorbic acid derivatives

Assignee: Showa Denko K.K.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,223,775
App. No.
10/510,756
Granted
May 29, 2007
Kind
B2
Abstract

An ascorbic acid derivative, which is a compound represented by the following general formula (1) or a salt thereof: [Chemical Formula 11] (1)(wherein X and Y each represents H or a protective group for OH, R 1 and R 2 each represents an alkyl group having from 1 to 19 carbon atoms, which may be linear or branched, and the total number of carbon atoms in R 1 R 2 is an integer of 5 to 22).

Claims (15)

1. An ascorbic acid derivative, which is a compound represented by the following general formula (1) or a salt thereof:

(wherein X and Y each represents H or a protective group for OH, R 1 and R 2 each represents an alkyl group having from 1 to 19 carbon atoms, which may be linear or branched, and the total number of carbon atoms in R 1 and R 2 is an integer of 5 to 22).

2. The ascorbic acid derivative according to claim 1 , which is a salt with one or more metal selected from the group consisting of alkali metal, alkaline earth metal, aluminum, iron, zinc and bismuth.

3. The ascorbic acid derivative according to claim 1 , which is a salt with ammonia, monoethanolamine, diethanolamine, triethanolamine, dicyclohexylamine or 2-amino-1-methylpropanol.

4. The ascorbic acid derivative according to any one of claims 1 to 3 , wherein the total number of carbon atoms in R 1 and R 2 of the general formula (1) is an integer of 8 to 18.

5. The ascorbic acid derivative according to claim 4 , wherein R 1 and R 2 of the general formula (1) are a linear alkyl group, and the total number of carbon atoms in the linear alkyl groups of R 1 and R 2 is 14 or 16.

6. The ascorbic acid derivative according to claim 5 , wherein in the general formula (1), R 1 is n-C 9 H 19 and R 2 is n-C 7 H 15 ; or R 1 is n-C 8 H 17 and R 2 is n-C 6 H 13 .

7. A process for producing an ascorbic acid derivative according to claim 1 , comprising a step of reacting a compound represented by the following general formula (2) and/or a salt thereof:

(wherein X and Y each represents H or a protective group for OH), with at least one selected from fatty acid, fatty acid salt, fatty acid ester, fatty acid halide, and/or fatty acid anhydride.

8. The process for producing an ascorbic acid derivative according to claim 7 , wherein the reaction is performed in the presence of a condensing agent and/or dehydrating agent.

9. The process for producing an ascorbic acid derivative according to claim 8 , wherein the dehydrating agent is sulfuric acid.

10. The process for producing an ascorbic acid derivative according to any one of claims 7 , wherein the reaction is conducted in a solvent selected from the group consisting of: water, acetone, dioxane, toluene, ethylbenzene, methyl-tert-butyl ether and sulfuric acid.

11. A vitamin C preparation comprising a therapeutically effective amount of the ascorbic acid derivative according to claim 1 as an effective ingredient.

12. A composition comprising a therapeutically effective amount of the ascorbic acid derivative according to claim 1 , in the form of a medical or pharmaceutical preparation, an agrochemical preparation or an animal drug preparation.

13. A composition comprising a therapeutically effective amount of the ascorbic acid derivative according to claim 1 , in the form of a food or feed additive.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2005
From: NISHIMURA, NORIHITO; ISHII, HIROSHI; SAITO, MAKOTO
To: SHOWA DENKO K.K.
Reel/Frame 017446/0580 →
Priority Claims (1)
JP 2002-110341 · Apr 12, 2002 · national
Continuity (2)
Provisional Application 6037360900 · Apr 19, 2002
Related Publication 20060100177A1 · May 11, 2006